WILMINGTON – Prelude Therapeutics, the burgeoning cancer treatment research company, recently named its first president while it furthers research on two lead drugs and preps two additional ones for studies. […]
© 2024 Delaware Business Times
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.